Page last updated: 2024-08-24

lercanidipine and Chronic Kidney Failure

lercanidipine has been researched along with Chronic Kidney Failure in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mancia, G; Tsioufis, K1
Burnier, M1
Calls, J; Gómez Campderá, F; Herrera, J; Liébana, A; Manjón, M; Marco, J; Martínez Fernández, J; Méndez, ML; Morey, A; Ocón, J; Pastor, L; Rincón, B; Robles, NR; Rodríguez Martínez, MA; Rodríguez Villareal, I; Tornero, F; Torrijos, J; Villatoro, J1
Calls, J; Gomez, CF; Herrera, J; Liebana, A; Manjon, M; Marco, J; Martinez, FI; Mendez, ML; Morey, A; Ocon, J; Pastor, L; Rincon, B; Robles, NR; Rodriguez, MM; Rodríguez, VI; Tornero, F; Torrijos, J; Villatoro, J1

Reviews

1 review(s) available for lercanidipine and Chronic Kidney Failure

ArticleYear
Renal protection with calcium antagonists: the role of lercanidipine.
    Current medical research and opinion, 2013, Volume: 29, Issue:12

    Topics: Amlodipine; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; PubMed

2013

Trials

1 trial(s) available for lercanidipine and Chronic Kidney Failure

ArticleYear
[Lercanidipine in diabetic patients with renal failure].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2004, Volume: 24, Issue:4

    Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Edema; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Treatment Outcome

2004

Other Studies

2 other study(ies) available for lercanidipine and Chronic Kidney Failure

ArticleYear
Current perspective on the use of calcium channel blockers to treat hypertensive patients: the role of lercanidipine.
    Future cardiology, 2019, Volume: 15, Issue:4

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Practice Guidelines as Topic; Precision Medicine

2019
Lercanidipine in patients with chronic renal failure: the ZAFRA study.
    Renal failure, 2005, Volume: 27, Issue:1

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Treatment Outcome

2005